{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:17:44Z","timestamp":1790713064090,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":1130,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1593\/neo.101372","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T13:11:47Z","timestamp":1429794707000},"page":"309-IN8","source":"Crossref","is-referenced-by-count":194,"title":["Targeted Delivery of Small Interfering RNA Using Reconstituted High-Density Lipoprotein Nanoparticles"],"prefix":"10.1016","volume":"13","author":[{"given":"Mian M.K.","family":"Shahzad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingegowda S.","family":"Mangala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Dong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Bottsford-Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna M.","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad V.","family":"Pecot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duangmani","family":"Thanapprapasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Won","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja","family":"Gaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya P.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirupama","family":"Sabnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Deavers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Seog","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee M.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Lopez-Berestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter J.","family":"McConathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo","family":"Prokai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andras G.","family":"Lacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1593\/neo.101372_bib1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1593\/neo.101372_bib2","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","volume":"391","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1593\/neo.101372_bib3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature02870","article-title":"Unlocking the potential of the human genome with RNA interference","volume":"431","author":"Hannon","year":"2004","journal-title":"Nature"},{"key":"10.1593\/neo.101372_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2007.03.005","article-title":"RNAi therapeutics: principles, prospects and challenges","volume":"59","author":"Aagaard","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1593\/neo.101372_bib5","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1056\/NEJMoa0803785","article-title":"Dicer, Drosha, and outcomes in patients with ovarian cancer","volume":"359","author":"Merritt","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1593\/neo.101372_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrd2742","article-title":"Knocking down barriers: advances in siRNA delivery","volume":"8","author":"Whitehead","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1593\/neo.101372_bib7","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1158\/1078-0432.CCR-06-0021","article-title":"Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy","volume":"12","author":"Halder","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.101372_bib8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/jnci\/djn024","article-title":"Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth","volume":"100","author":"Merritt","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1593\/neo.101372_bib9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm1447","article-title":"Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma","volume":"12","author":"Thaker","year":"2006","journal-title":"Nat Med"},{"key":"10.1593\/neo.101372_bib10","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1158\/0008-5472.CAN-07-5810","article-title":"Targeted delivery of small interfering RNA: approaching effective cancer therapies","volume":"68","author":"Pirollo","year":"2008","journal-title":"Cancer Res"},{"key":"10.1593\/neo.101372_bib11","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nbt1339","article-title":"Mechanisms and optimization of in vivo delivery of lipophilic siRNAs","volume":"25","author":"Wolfrum","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1593\/neo.101372_bib12","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1158\/0008-5472.CAN-06-1668","article-title":"Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner","volume":"67","author":"Zhang","year":"2007","journal-title":"Cancer Res"},{"key":"10.1593\/neo.101372_bib13","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/ATVBAHA.108.179507","article-title":"The molecular mechanisms of HDL and associated vesicular trafficking mechanisms to mediate cellular lipid homeostasis","volume":"29","author":"Schmitz","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1593\/neo.101372_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1388-1981(00)00035-4","article-title":"Lipoprotein-associated \u03b1-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBL-100 breast cancer cells","volume":"1485","author":"Pussinen","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1593\/neo.101372_bib15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1081\/ERC-200043979","article-title":"SR-BI and HDL cholesteryl ester metabolism","volume":"30","author":"Connelly","year":"2004","journal-title":"Endocr Res"},{"key":"10.1593\/neo.101372_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00041433-200406000-00008","article-title":"Scavenger receptor BI: a scavenger receptor with a mission to transport high density lipoprotein lipids","volume":"15","author":"Connelly","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1593\/neo.101372_bib17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/pros.21072","article-title":"Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model","volume":"70(4)","author":"Leon","year":"2010","journal-title":"Prostate"},{"key":"10.1593\/neo.101372_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/187221107780831914","article-title":"Recent developments and patenting of lipoprotein based formulations","volume":"1","author":"Lacko","year":"2007","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"10.1593\/neo.101372_bib19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1517\/17425247.4.6.665","article-title":"Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs","volume":"4","author":"Lacko","year":"2007","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1593\/neo.101372_bib20","first-page":"2045","article-title":"High density lipoprotein complexes as delivery vehicles for anticancer drugs","volume":"22","author":"Lacko","year":"2002","journal-title":"Anticancer Res"},{"key":"10.1593\/neo.101372_bib21","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1021\/bc8002259","article-title":"Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging","volume":"20","author":"Kamaly","year":"2009","journal-title":"Bioconjug Chem"},{"key":"10.1593\/neo.101372_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1210\/er.2001-0037","article-title":"The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues","volume":"24","author":"Rigotti","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1593\/neo.101372_bib23","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1074\/jbc.M808211200","article-title":"Normal hepatic cell surface localization of the high density lipoprotein receptor, scavenger receptor class B, type I, depends on all four PDZ domains of PDZK1","volume":"284","author":"Fenske","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.101372_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/10611860903156419","article-title":"Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier","volume":"18","author":"Mooberry","year":"2010","journal-title":"J Drug Target"},{"key":"10.1593\/neo.101372_bib25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1080\/10611860802200938","article-title":"Recombinant high-density lipoprotein complex as a targeting system of nosiheptide to liver cells","volume":"16","author":"Feng","year":"2008","journal-title":"J Drug Target"},{"key":"10.1593\/neo.101372_bib26","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.271.5248.518","article-title":"Identification of scavenger receptor SR-BI as a high density lipoprotein receptor","volume":"271","author":"Acton","year":"1996","journal-title":"Science"},{"key":"10.1593\/neo.101372_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrc2966","article-title":"RNA interference in the clinic: challenges and future directions","volume":"11","author":"Pecot","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1593\/neo.101372_bib28","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","article-title":"STATs and gene regulation","volume":"277","author":"Darnell","year":"1997","journal-title":"Science"},{"key":"10.1593\/neo.101372_bib29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1517\/14728222.8.5.409","article-title":"STAT proteins as novel targets for cancer drug discovery","volume":"8","author":"Turkson","year":"2004","journal-title":"Expert Opin Ther Targets"},{"key":"10.1593\/neo.101372_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/13543780802565791","article-title":"Targeting STAT3 in cancer: how successful are we?","volume":"18","author":"Yue","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1593\/neo.101372_bib31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1083\/jcb.200212114","article-title":"Differential regulation of cell motility and invasion by FAK","volume":"160","author":"Hsia","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1593\/neo.101372_bib32","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ijc.1605","article-title":"CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase","volume":"97","author":"Kohno","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1593\/neo.101372_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1500001","article-title":"The focal adhesion kinase","volume":"150","author":"Schaller","year":"1996","journal-title":"J Endocrinol"},{"key":"10.1593\/neo.101372_bib34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35010517","article-title":"FAK integrates growth-factor and integrin signals to promote cell migration","volume":"2","author":"Sieg","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1593\/neo.101372_bib35","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0002-9440(10)63370-6","article-title":"Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasion","volume":"165","author":"Sood","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1593\/neo.101372_bib36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/CAD.0b013e3282f1da86","article-title":"Evaluation of synthetic\/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel","volume":"19","author":"McConathy","year":"2008","journal-title":"Anticancer Drugs"},{"key":"10.1593\/neo.101372_bib37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1046-5928(02)00568-5","article-title":"Optimized bacterial expression of human apolipoprotein A-I","volume":"27","author":"Ryan","year":"2003","journal-title":"Protein Expr Purif"},{"key":"10.1593\/neo.101372_bib38","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.4161\/cbt.8.11.8523","article-title":"Dual targeting of EphA2 and FAK in ovarian carcinoma","volume":"8","author":"Shahzad","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1593\/neo.101372_bib39","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1158\/0008-5472.CAN-08-2246","article-title":"Synergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress","volume":"69","author":"Kopetz","year":"2009","journal-title":"Cancer Res"},{"key":"10.1593\/neo.101372_bib40","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1158\/1078-0432.CCR-05-1728","article-title":"Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cells","volume":"11","author":"Halder","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.101372_bib41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccr.2010.06.016","article-title":"Regulation of tumor angiogenesis by EZH2","volume":"18","author":"Lu","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1593\/neo.101372_bib42","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/jnci\/djj414","article-title":"Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer","volume":"98","author":"Landen","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1593\/neo.101372_bib43","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/jnci\/djp231","article-title":"EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma","volume":"101","author":"Lee","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1593\/neo.101372_bib44","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1158\/1078-0432.CCR-04-2060","article-title":"Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors","volume":"11","author":"Thaker","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.101372_bib45","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1073\/pnas.98.4.1543","article-title":"Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1","volume":"98","author":"Shen","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.101372_bib46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1074-7613(00)80011-4","article-title":"Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells","volume":"10","author":"Catlett-Falcone","year":"1999","journal-title":"Immunity"},{"key":"10.1593\/neo.101372_bib47","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/(SICI)1097-0215(19981029)78:3<326::AID-IJC12>3.0.CO;2-4","article-title":"STAT3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells","volume":"78","author":"Zushi","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1593\/neo.101372_bib48","first-page":"3351","article-title":"Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma","volume":"62","author":"Masuda","year":"2002","journal-title":"Cancer Res"},{"key":"10.1593\/neo.101372_bib49","first-page":"117","article-title":"In vivo application of RNA interference: from functional genomics to therapeutics","volume":"54","author":"Lu","year":"2005","journal-title":"Adv Genet"},{"key":"10.1593\/neo.101372_bib50","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1517\/17425247.2.4.639","article-title":"On the delivery of small interfering RNAs into mammalian cells","volume":"2","author":"Sioud","year":"2005","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1593\/neo.101372_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/B:PHAM.0000012145.49054.6c","article-title":"Pharmaceutical prospects for RNA interference","volume":"21","author":"Schiffelers","year":"2004","journal-title":"Pharm Res"},{"key":"10.1593\/neo.101372_bib52","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1158\/0008-5472.CAN-05-0530","article-title":"Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery","volume":"65","author":"Landen","year":"2005","journal-title":"Cancer Res"},{"key":"10.1593\/neo.101372_bib53","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature03121","article-title":"Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs","volume":"432","author":"Soutschek","year":"2004","journal-title":"Nature"},{"key":"10.1593\/neo.101372_bib54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1517\/17425240902780166","article-title":"Ligand-based targeted therapy for cancer tissue","volume":"6","author":"Das","year":"2009","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1593\/neo.101372_bib55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1535-6108(04)00028-5","article-title":"Inactivation of Stat3 in tumor cells: releasing a brake on immune responses against cancer?","volume":"5","author":"Gamero","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1593\/neo.101372_bib56","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1038\/nm1325","article-title":"Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity","volume":"11","author":"Kortylewski","year":"2005","journal-title":"Nat Med"},{"key":"10.1593\/neo.101372_bib57","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/onc.2008.448","article-title":"The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-\u03b2 signaling","volume":"28","author":"Lin","year":"2009","journal-title":"Oncogene"},{"key":"10.1593\/neo.101372_bib58","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.onc.1205260","article-title":"Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis","volume":"21","author":"Niu","year":"2002","journal-title":"Oncogene"},{"key":"10.1593\/neo.101372_bib59","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/sj.onc.1206122","article-title":"Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis","volume":"22","author":"Wei","year":"2003","journal-title":"Oncogene"},{"key":"10.1593\/neo.101372_bib60","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/sj.onc.1206226","article-title":"Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway","volume":"22","author":"Wei","year":"2003","journal-title":"Oncogene"},{"key":"10.1593\/neo.101372_bib61","first-page":"3106","article-title":"Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colorectal adenocarcinomas","volume":"7","author":"Ayaki","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.101372_bib62","first-page":"2417","article-title":"Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes","volume":"6","author":"Cance","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.101372_bib63","first-page":"2752","article-title":"Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumors","volume":"55","author":"Owens","year":"1995","journal-title":"Cancer Res"},{"key":"10.1593\/neo.101372_bib64","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/(SICI)1097-0215(19961009)68:2<169::AID-IJC4>3.0.CO;2-W","article-title":"Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma","volume":"68","author":"Tremblay","year":"1996","journal-title":"Int J Cancer"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558611800126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558611800126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T07:15:44Z","timestamp":1598944544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558611800126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1476558611800126"],"URL":"https:\/\/doi.org\/10.1593\/neo.101372","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}